Lucid Diagnostics Inc (LUCD) returns
Lucid Diagnostics returns over 5 years
$1,000 invested in Lucid Diagnostics five years ago was worth $40.60 at the close on October 30, 2026, with dividends reinvested: an average return of -47.3% a year. The same $1,000 in the S&P 500 (SPY) became $1,760.
Total return by period
| Period | Total return | A year, on average | $1,000 became | S&P 500 (SPY) |
|---|---|---|---|---|
| 1 month | -46.1% | — | $539.02 | -0.9% |
| 3 months | -55.1% | — | $449.18 | +2.1% |
| Year to date | -62.9% | — | $371.38 | +11.7% |
| 1 year | -66.3% | — | $337.33 | +12.4% |
| 3 years | -68.6% | -32.0% | $313.80 | +88.5% |
| 5 years | -95.9% | -47.3% | $40.60 | +76.0% |
Lucid Diagnostics return by calendar year
| Year | LUCD | S&P 500 (SPY) | Difference |
|---|---|---|---|
| 2026 to date | -62.9% | +11.7% | -74.6% |
| 2025 | +33.1% | +17.7% | +15.4% |
| 2024 | -41.9% | +24.9% | -66.8% |
| 2023 | +3.7% | +26.2% | -22.5% |
| 2022 | -74.7% | -18.2% | -56.5% |
Past returns do not predict future returns. Returns are computed from our daily closes, adjusted for splits and with dividends reinvested on their ex-dates; taxes and trading costs are left out.
See also: LUCD financials
No forecast, no recommendation. This page describes Lucid Diagnostics Inc from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.